Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-01-22
1989-05-16
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514253, 544230, 544237, 544284, 544359, 544363, 544366, 544367, 544368, 544372, 544373, A61K 31495, C07D41714
Patent
active
048310310
ABSTRACT:
Arylpiperazinyl-ethyl(or butyl)-heterocyclic compounds and their pharmaceutically acceptable acid addition salts are neuroleptic agents. They are useful in the treatment of psychotic disorders.
REFERENCES:
patent: 3133056 (1964-05-01), Ash et al.
patent: 3147260 (1964-09-01), Ash et al.
patent: 4113728 (1978-09-01), Baggaley
Munson et al, Chem. Abst. vol. 98(1983) 143284e "4-amino-3-quinolinecarboxylic acids and esters as antisecretory anti-ulcer compounds".
Lowe, III John A.
Nagel Arthur A.
Akers Lawrence C.
Daus Donald G.
Holtrust Gezina
Pfizer Inc.
Richardson Peter C.
LandOfFree
Aryl piperazinyl-(C.sub.2 or C.sub.4) alkylene heterocyclic comp does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl piperazinyl-(C.sub.2 or C.sub.4) alkylene heterocyclic comp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl piperazinyl-(C.sub.2 or C.sub.4) alkylene heterocyclic comp will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2322802